MedTrace Logo

Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

NCT02854943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2623

Last updated 2022-12-07

No results posted yet for this study

Summary

Retrospective analysis of ferritin, outcome and HLH-criteria in critically ill patients.

Conditions

  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Macrophage Activation Syndrome (MAS)
  • Hemophagocytic Syndromes

Sponsors & Collaborators

  • Gunnar Lachmann

    lead OTHER

Principal Investigators

  • Gunnar Lachmann, MD · Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine

  • Gunnar Lachmann, MD · Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Operative Intensive Care Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2018-08-31
Completion
2018-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854943 on ClinicalTrials.gov